Clinical Trial Update: Radiotherapy in Association With Cetuximab in Patients Treated for an Epidermoid Cancer

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating radiotherapy in combination with cetuximab for epidermoid head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Epidermoid Head and Neck Cancer | Status: COMPLETED